Works matching AU Galluzzo, Marco

Results: 60
    1

    Effectiveness and safety of ustekinumab in naïve or TNF-inhibitors failure psoriatic arthritis patients: a 24-month prospective multicentric study.

    Published in:
    Clinical Rheumatology, 2018, v. 37, n. 2, p. 397, doi. 10.1007/s10067-017-3953-6
    By:
    • Chimenti, Maria Sole;
    • Ortolan, Augusta;
    • Lorenzin, Mariagrazia;
    • Triggianese, Paola;
    • Talamonti, Marina;
    • Costa, Luisa;
    • Caso, Francesco;
    • Favero, Marta;
    • Teoli, Miriam;
    • Galluzzo, Marco;
    • Scarpa, Raffaele;
    • Punzi, Leonardo;
    • Perricone, Roberto;
    • Ramonda, Roberta
    Publication type:
    Article
    2
    3
    4
    5

    Brodalumab for the Treatment of Moderate-to-Severe Psoriasis: An Expert Delphi Consensus Statement.

    Published in:
    Journal of Clinical Medicine, 2023, v. 12, n. 10, p. 3545, doi. 10.3390/jcm12103545
    By:
    • Fargnoli, Maria Concetta;
    • Bardazzi, Federico;
    • Bianchi, Luca;
    • Dapavo, Paolo;
    • Fabbrocini, Gabriella;
    • Gisondi, Paolo;
    • Micali, Giuseppe;
    • Offidani, Anna Maria;
    • Pellacani, Giovanni;
    • Skroza, Nevena;
    • Angileri, Rosa Giuseppa;
    • Burlando, Martina;
    • Campanati, Anna;
    • Carrera, Carlo Giovanni;
    • Chiricozzi, Andrea;
    • Conti, Andrea;
    • Simone, Clara De;
    • Di Lernia, Vito;
    • Errichetti, Enzo;
    • Galluzzo, Marco
    Publication type:
    Article
    6
    7
    8
    9
    10
    11

    Skin immunity and its dysregulation in psoriasis.

    Published in:
    Cell Cycle, 2019, v. 18, n. 20, p. 2581, doi. 10.1080/15384101.2019.1653099
    By:
    • Lanna, Caterina;
    • Mancini, Mara;
    • Gaziano, Roberta;
    • Cannizzaro, Maria Vittoria;
    • Galluzzo, Marco;
    • Talamonti, Marina;
    • Rovella, Valentina;
    • Annicchiarico-Petruzzelli, Margherita;
    • Melino, Gerry;
    • Wang, Ying;
    • Shi, Yufang;
    • Campione, Elena;
    • Bianchi, Luca
    Publication type:
    Article
    12

    Successful response of upadacitinib in different clinical phenotypes of atopic dermatitis.

    Published in:
    Journal of the European Academy of Dermatology & Venereology, 2025, v. 39, n. 6, p. e547, doi. 10.1111/jdv.20568
    By:
    • Gori, Niccolò;
    • Quaglino, Pietro;
    • Chiricozzi, Andrea;
    • Marzano, Angelo Valerio;
    • Argenziano, Giuseppe;
    • Girolomoni, Giampiero;
    • Bianchi, Luca;
    • Fargnoli, Maria Concetta;
    • Ortoncelli, Michela;
    • Di Nardo, Lucia;
    • Ferrucci, Silvia Mariel;
    • Caccavale, Stefano;
    • Maurelli, Martina;
    • Galluzzo, Marco;
    • Esposito, Maria;
    • Peris, Ketty
    Publication type:
    Article
    13

    Successful response to tralokinumab in patients unresponsive, intolerant or with contraindications to dupilumab and JAK inhibitors: A case series.

    Published in:
    Journal of the European Academy of Dermatology & Venereology, 2024, v. 38, n. 10, p. e852, doi. 10.1111/jdv.19929
    By:
    • Gori, Niccolò;
    • Ippoliti, Elena;
    • Ferrucci, Silvia Mariel;
    • Balato, Anna;
    • Ortoncelli, Michela;
    • Maurelli, Martina;
    • Galluzzo, Marco;
    • Munera Campos, Monica;
    • Seremet, Teofila;
    • Di Nardo, Lucia;
    • Antonelli, Flaminia;
    • Coscarella, Giulia;
    • Conrad, Curdin;
    • Carrascosa, Jose Manuel;
    • Bianchi, Luca;
    • Argenziano, Giuseppe;
    • Ribero, Simone;
    • Girolomoni, Giampiero;
    • Marzano, Angelo Valerio;
    • Chiricozzi, Andrea
    Publication type:
    Article
    14
    15

    Real‐life effectiveness and safety of guselkumab in patients with psoriasis who have an inadequate response to ustekinumab: A 104‐week multicenter retrospective study – IL PSO (ITALIAN LANDSCAPE PSORIASIS).

    Published in:
    Journal of the European Academy of Dermatology & Venereology, 2023, v. 37, n. 5, p. 1017, doi. 10.1111/jdv.18913
    By:
    • Gargiulo, Luigi;
    • Ibba, Luciano;
    • Malagoli, Piergiorgio;
    • Angileri, Rosa Giuseppa;
    • Bardazzi, Federico;
    • Bernardini, Nicoletta;
    • Burlando, Martina;
    • Carrera, Carlo G.;
    • Chiricozzi, Andrea;
    • Dapavo, Paolo;
    • Dini, Valentina;
    • Fabbrocini, Gabriella;
    • Gaiani, Francesca Maria;
    • Galluzzo, Marco;
    • Giofré, Claudia;
    • Guarneri, Claudio;
    • Loconsole, Francesco;
    • Malara, Giovanna;
    • Marcelli, Lorenzo;
    • Megna, Matteo
    Publication type:
    Article
    16
    17

    Real-Life Experience with Tildrakizumab in Plaque Psoriasis with Palmoplantar Involvement: A Multi-Center Retrospective Italian Study.

    Published in:
    Dermatology & Therapy, 2025, v. 15, n. 2, p. 323, doi. 10.1007/s13555-025-01339-9
    By:
    • Diotallevi, Federico;
    • Esposito, Maria;
    • Fargnoli, Maria Concetta;
    • Quaglino, Pietro;
    • Mastorino, Luca;
    • Stingeni, Luca;
    • Hansel, Katharina;
    • Feliciani, Claudio;
    • Megna, Matteo;
    • Gallo, Lucia;
    • Legori, Agostina;
    • Argenziano, Giuseppe;
    • Balato, Anna;
    • Bardazzi, Federico;
    • Burlando, Martina;
    • Cozzani, Emanuele;
    • Bianchi, Luca;
    • Galluzzo, Marco;
    • Gisondi, Paolo;
    • Bellinato, Francesco
    Publication type:
    Article
    18

    A Multidisciplinary Approach Is Beneficial in Atopic Dermatitis.

    Published in:
    Dermatology & Therapy, 2024, v. 14, n. 6, p. 1443, doi. 10.1007/s13555-024-01185-1
    By:
    • Amerio, Paolo;
    • Ferrucci, Silvia Mariel;
    • Galluzzo, Marco;
    • Napolitano, Maddalena;
    • Narcisi, Alessandra;
    • Levi, Anna;
    • Di Fino, Sara;
    • Palladino, Chiara;
    • Patruno, Cataldo;
    • Rossi, Mariateresa
    Publication type:
    Article
    19

    A Real-Life Study on the Use of Tildrakizumab in Psoriatic Patients.

    Published in:
    Pharmaceuticals (14248247), 2023, v. 16, n. 4, p. 526, doi. 10.3390/ph16040526
    By:
    • Campione, Elena;
    • Lambiase, Sara;
    • Gaeta Shumak, Ruslana;
    • Galluzzo, Marco;
    • Lanna, Caterina;
    • Costanza, Gaetana;
    • Borselli, Cristiana;
    • Artosi, Fabio;
    • Cosio, Terenzio;
    • Tofani, Lorenzo;
    • Dattola, Annunziata;
    • Di Daniele, Francesca;
    • Bianchi, Luca
    Publication type:
    Article
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29

    A microarray‐based IgE‐molecular mimicry index (IgE‐MMI): A biomarker for disease severity, clinical phenotypes, and therapeutic response in atopic dermatitis?

    Published in:
    Allergy, 2024, v. 79, n. 12, p. 3415, doi. 10.1111/all.16377
    By:
    • Scala, Enrico;
    • Madonna, Stefania;
    • Abeni, Damiano;
    • Cecchi, Lorenzo;
    • Cocuroccia, Barbara;
    • Dattolo, Anna;
    • Moretta, Gaia;
    • Provini, Alessia;
    • Russo, Filomena;
    • Sordi, Donatella;
    • Pallotta, Sabatino;
    • Galluzzo, Marco;
    • Talamonti, Marina;
    • Villella, Valeria;
    • Giani, Mauro;
    • Caprini, Elisabetta;
    • Albanesi, Cristina;
    • Villalta, Danilo;
    • Asero, Riccardo;
    • Matricardi, Paolo Maria
    Publication type:
    Article
    30

    Management of patients with atopic dermatitis undergoing systemic therapy during COVID‐19 pandemic in Italy: Data from the DA‐COVID‐19 registry.

    Published in:
    Allergy, 2021, v. 76, n. 6, p. 1813, doi. 10.1111/all.14767
    By:
    • Chiricozzi, Andrea;
    • Talamonti, Marina;
    • De Simone, Clara;
    • Galluzzo, Marco;
    • Gori, Niccolò;
    • Fabbrocini, Gabriella;
    • Marzano, Angelo Valerio;
    • Girolomoni, Giampiero;
    • Offidani, Annamaria;
    • Rossi, Maria Teresa;
    • Bianchi, Luca;
    • Cristaudo, Antonio;
    • Fierro, Maria Teresa;
    • Stingeni, Luca;
    • Pellacani, Giovanni;
    • Argenziano, Giuseppe;
    • Patrizi, Annalisa;
    • Pigatto, Paolo;
    • Romanelli, Marco;
    • Savoia, Paola
    Publication type:
    Article
    31

    Efficacy and safety of tildrakizumab in elderly patients: real-world multicenter study (ESTER – study).

    Published in:
    Journal of Dermatological Treatment, 2024, v. 35, n. 1, p. 1, doi. 10.1080/09546634.2024.2319304
    By:
    • Orsini, Diego;
    • Caldarola, Giacomo;
    • Dattola, Annunziata;
    • Campione, Elena;
    • Bernardini, Nicoletta;
    • Frascione, Pasquale;
    • De Simone, Clara;
    • Richetta, Antonio G.;
    • Galluzzo, Marco;
    • Skroza, Nevena;
    • Assorgi, Chiara;
    • Amore, Emanuele;
    • Falco, Gennaro M.;
    • Gaeta Shumak, Ruslana;
    • Artosi, Fabio;
    • Maretti, Giulia;
    • Potenza, Concetta;
    • Bianchi, Luca;
    • Pellacani, Giovanni;
    • Peris, Ketty
    Publication type:
    Article
    32

    Analysis of predictive factors influencing dupilumab continuation rate in adult patients with atopic dermatitis: results from an Italian multicenter study.

    Published in:
    Journal of Dermatological Treatment, 2023, v. 34, n. 1, p. 1, doi. 10.1080/09546634.2023.2230685
    By:
    • Gori, Niccolò;
    • Sernicola, Alvise;
    • Tolino, Ersilia;
    • Mariano, Maria;
    • Galluzzo, Marco;
    • Moretta, Gaia;
    • Coppola, Rosa;
    • D'Alessio, Andrea;
    • Sansone, Massimo;
    • Maffei, Virginia;
    • Paolino, Claudia;
    • Ferrao, Cristian;
    • Cascia, Lauro;
    • Addio, Paola;
    • Di Nardo, Lucia;
    • Chiricozzi, Andrea;
    • Del Duca, Ester;
    • Cristaudo, Antonio;
    • Bianchi, Luca;
    • Pallotta, Sabatino
    Publication type:
    Article
    33

    Long-Term Drug Survival and Effectiveness of Secukinumab in Patients with Moderate to Severe Chronic Plaque Psoriasis: 42-Month Results from the SUPREME 2.0 Study.

    Published in:
    Clinical, Cosmetic & Investigational Dermatology, 2023, v. 16, p. 3561, doi. 10.2147/CCID.S416149
    By:
    • Russo, Filomena;
    • Galluzzo, Marco;
    • Stingeni, Luca;
    • Persechino, Severino;
    • Zichichi, Leonardo;
    • Conti, Andrea;
    • Giofrè, Claudia;
    • Dini, Valentina;
    • Vispi, Martina;
    • Atzori, Laura;
    • Cattaneo, Angelo;
    • Parodi, Aurora;
    • Bardazzi, Federico;
    • Stinco, Giuseppe;
    • Dapavo, Paolo;
    • Girolomoni, Giampiero;
    • Musumeci, Maria Letizia;
    • Papini, Manuela;
    • Venturini, Marina;
    • Dastoli, Stefano
    Publication type:
    Article
    34
    35

    Real-world outcomes in patients with moderate-to-severe plaque psoriasis treated with guselkumab for up to 1 year.

    Published in:
    Expert Opinion on Biological Therapy, 2022, v. 22, n. 12, p. 1585, doi. 10.1080/14712598.2022.2090835
    By:
    • Galluzzo, Marco;
    • Talamonti, Marina;
    • Bernardini, Nicoletta;
    • Chiricozzi, Andrea;
    • De Simone, Clara;
    • Bonifati, Claudio;
    • Bruni, Pierluigi;
    • Diotallevi, Federico;
    • Esposito, Maria;
    • Graceffa, Dario;
    • Hansel, Katharina;
    • Loconsole, Francesco;
    • Moretta, Gaia;
    • Mugheddu, Cristina;
    • Papini, Manuela;
    • Richetta, Antonio;
    • Skroza, Nevena;
    • Atzori, Laura;
    • Fargnoli, Maria Concetta;
    • Persechino, Severino
    Publication type:
    Article
    36

    Secukinumab for the treatment of palmoplantar psoriasis: a 2-year, multicenter, real-life observational study.

    Published in:
    Expert Opinion on Biological Therapy, 2022, v. 22, n. 4, p. 547, doi. 10.1080/14712598.2022.2029841
    By:
    • Galluzzo, Marco;
    • Talamonti, Marina;
    • Atzori, Laura;
    • Bardazzi, Federico;
    • Campanati, Anna;
    • Di Cesare, Antonella;
    • Diotallevi, Federico;
    • Flori, Maria Laura;
    • Mugheddu, Cristina;
    • Offidani, Annamaria;
    • Piaserico, Stefano;
    • Russo, Filomena;
    • Sacchelli, Lidia;
    • Bianchi, Luca;
    • Prignano, Francesca
    Publication type:
    Article
    37

    Tildrakizumab for treatment of moderate to severe psoriasis: an expert opinion of efficacy, safety, and use in special populations.

    Published in:
    Expert Opinion on Biological Therapy, 2022, v. 22, n. 3, p. 367, doi. 10.1080/14712598.2022.1988566
    By:
    • Galluzzo, Marco;
    • Chiricozzi, Andrea;
    • Cinotti, Elisa;
    • Brunasso, Giovanna;
    • Congedo, Maurizio;
    • Esposito, Maria;
    • Franchi, Chiara;
    • Malara, Giovanna;
    • Narcisi, Alessandra;
    • Piaserico, Stefano;
    • Tiberio, Rossana;
    • Argenziano, Giuseppe;
    • Fabbrocini, Gabriella;
    • Parodi, Aurora
    Publication type:
    Article
    38

    HLA-Cw6 and other HLA-C alleles, as well as MICB-DT, DDX58, and TYK2 genetic variants associate with optimal response to anti-IL-17A treatment in patients with psoriasis.

    Published in:
    Expert Opinion on Biological Therapy, 2021, v. 21, n. 2, p. 259, doi. 10.1080/14712598.2021.1862082
    By:
    • Morelli, Martina;
    • Galluzzo, Marco;
    • Madonna, Stefania;
    • Scarponi, Claudia;
    • Scaglione, Giovanni Luca;
    • Galluccio, Tiziana;
    • Andreani, Marco;
    • Pallotta, Sabatino;
    • Girolomoni, Giampiero;
    • Bianchi, Luca;
    • Talamonti, Marina;
    • Albanesi, Cristina
    Publication type:
    Article
    39

    Characteristic of chronic plaque psoriasis patients treated with biologics in Italy during the COVID-19 Pandemic: Risk analysis from the PSO-BIO-COVID observational study.

    Published in:
    Expert Opinion on Biological Therapy, 2021, v. 21, n. 2, p. 271, doi. 10.1080/14712598.2021.1853698
    By:
    • Talamonti, Marina;
    • Galluzzo, Marco;
    • Chiricozzi, Andrea;
    • Quaglino, Pietro;
    • Fabbrocini, Gabriella;
    • Gisondi, Paolo;
    • Marzano, Angelo Valerio;
    • Potenza, Concetta;
    • Conti, Andrea;
    • Parodi, Aurora;
    • Piaserico, Stefano;
    • Bardazzi, Federico;
    • Argenziano, Giuseppe;
    • Rongioletti, Franco;
    • Stingeni, Luca;
    • Micali, Giuseppe;
    • Loconsole, Francesco;
    • Rossi, Maria Teresa;
    • Bongiorno, Maria Rita;
    • Feliciani, Claudio
    Publication type:
    Article
    40
    41
    42
    43
    44
    45

    Tildrakizumab for treating psoriasis.

    Published in:
    Expert Opinion on Biological Therapy, 2017, v. 17, n. 5, p. 645, doi. 10.1080/14712598.2017.1304537
    By:
    • Galluzzo, Marco;
    • D’adamio, Simone;
    • Bianchi, Luca;
    • Talamonti, Marina
    Publication type:
    Article
    46
    47
    48
    49
    50

    Safety and Effectiveness of Upadacitinib in Patients with Moderate-to-Severe Atopic Dermatitis Who Smoke: a 2-Year Real-Life Multicenter Study.

    Published in:
    American Journal of Clinical Dermatology, 2025, v. 26, n. 3, p. 425, doi. 10.1007/s40257-025-00926-y
    By:
    • Leo, Francesco;
    • Ortoncelli, Michela;
    • Cascio Ingurgio, Ruggero;
    • Galli, Benedetta;
    • Grigolato, Laura;
    • Paganini, Claudia;
    • Maurelli, Martina;
    • Di Brizzi, Eugenia Veronica;
    • Lauletta, Giuseppe;
    • Barei, Francesca;
    • Fiasconaro, Chiara Anna;
    • Casale Alloa, Marta;
    • Guanti, Mario Bruno;
    • Gori, Niccolò;
    • Chiricozzi, Andrea;
    • Napolitano, Maddalena;
    • Patruno, Cataldo;
    • Galluzzo, Marco;
    • Rossi, Mariateresa;
    • Balato, Anna
    Publication type:
    Article